Craig Hallum Lowers Enovix (NASDAQ:ENVX) Price Target to $10.00

Enovix (NASDAQ:ENVX) had its price target cut by investment analysts at Craig Hallum from $16.00 to $10.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Craig Hallum’s target price would suggest a potential upside of 89.75% from the company’s current price.

ENVX has been the topic of a number of other research reports. Canaccord Genuity Group reduced their price target on Enovix from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Northland Securities set a $16.00 target price on Enovix in a report on Monday, November 17th. Cantor Fitzgerald decreased their price target on Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Enovix in a research report on Monday, December 29th. Finally, Oppenheimer reiterated an “outperform” rating on shares of Enovix in a research note on Thursday. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $15.65.

Enovix Stock Performance

NASDAQ ENVX opened at $5.27 on Thursday. The firm has a 50-day moving average price of $7.10 and a two-hundred day moving average price of $8.90. Enovix has a 12-month low of $5.24 and a 12-month high of $16.49. The company has a market capitalization of $1.14 billion, a P/E ratio of -6.84 and a beta of 2.13. The company has a quick ratio of 9.47, a current ratio of 9.72 and a debt-to-equity ratio of 1.74.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ENVX. Vanguard Group Inc. lifted its holdings in shares of Enovix by 10.9% in the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after acquiring an additional 1,747,145 shares during the last quarter. Millennium Management LLC increased its position in Enovix by 1,038.9% during the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock worth $14,724,000 after purchasing an additional 1,347,200 shares in the last quarter. Two Sigma Investments LP lifted its stake in Enovix by 9,197.1% in the 3rd quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock valued at $11,974,000 after purchasing an additional 1,188,079 shares during the last quarter. Barclays PLC boosted its position in Enovix by 263.1% in the fourth quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock valued at $11,345,000 after buying an additional 1,124,480 shares in the last quarter. Finally, Electron Capital Partners LLC grew its stake in shares of Enovix by 13.8% during the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock worth $80,143,000 after buying an additional 972,103 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix News Roundup

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Q4 results beat expectations: revenue of ~$11.3M (+~16% YoY) topped estimates and EPS/loss was slightly better than forecast; gross profit and operating-loss improvement were highlighted on the call — a fundamental bright spot supporting longer‑term growth potential. SA Q4 Presentation
• Positive Sentiment: Multiple outlets noted the revenue and EPS beats and operational improvement (higher gross profit, narrower operating loss), which help the growth narrative even as profitability remains distant. Yahoo Finance: Q4 Report
• Neutral Sentiment: Unusual options activity: a large block of call buying (≈31,896 calls) indicates speculative/leveraged interest that may amplify intraday moves but doesn’t change fundamentals. AAII Options Note
• Neutral Sentiment: Some analysts lowered price targets but kept constructive ratings (e.g., Canaccord trimmed its PT but remains “Buy”), which mutes upside while signaling continued long‑term conviction from parts of the sell‑side. Benzinga: Canaccord Note
• Negative Sentiment: Near‑term guidance disappointed: Q1 FY2026 revenue guidance ($6.5M–$7.5M) came in well below consensus (~$8.8M), a key proximate reason for selling pressure as it implies slower near‑term growth. Company Press Release / Deck
• Negative Sentiment: Analyst downgrades/target cuts: TD Cowen cut its target sharply and moved to “Hold,” and other firms trimmed targets — increasing near‑term downside risk as sell‑side expectations are reset. Benzinga: TD Cowen Note
• Negative Sentiment: New risk disclosure highlights rising geopolitical/trade exposure (U.S.–China tensions) that could pressure supply chains and margins — a fresh governance/operational risk investors must price in. TipRanks: Risk Disclosure
• Negative Sentiment: Balance‑sheet and liquidity signals are concerning to some investors: cash fell year‑over‑year and total liabilities rose materially; coupled with insider sales called out in reporting, that has likely amplified selling. Quiver Quant: Financials

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.